A leading charity in the UK has warned that about 80 per cent of the people suffering from multiple sclerosis are misdiagnosed by the doctors in the country.
A survey conducted by the MS Society of more than 1,500 people with multiple sclerosis found that about 81 per cent were misdiagnosed by their GPs. The study also showed that 28 per cent were told that they have a trapped nerve, 10 per cent were told that they have depression or anxiety or stress while 11 per cent were told that they suffered a stroke.
Experts said that there are more than 100,000 people living with multiple sclerosis in the UK and 5,000 are newly diagnosed every year. They said that it is the most common disabling neurological condition in young adults and symptoms starting in the 20s and 30s.
The MS Society has warned that the awareness level remains very low in the country and steps are required to be taken to address the issue. It pointed out that several symptoms are invisible and people might be suffering from numbness, tingling, problems with mobility and balance, vision and dizziness, fatigue, bladder problems, muscle stiffness or pain.
In a recently published blog post, "social media theorist" and Snapchat researcher Nathan Jurgenson has revealed that Snapchat is funding a new online magazine called 'Real Life.'
In announcing that Snapchat is bankrolling the new 'Real...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recently published blog post, "social media...
With tech giant Google scheduled to launch the Play...
Monohm Inc.’s incredibly weird circular smartphone-cum-...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).